AMD11070

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Genzyme, a Sanofi Company

Conditions

HIV InfectionsX4 Tropic Virus

Phase 1

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

CompletedNCT00089466

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2004-11-30End: 2009-01-31Updated: 2021-11-09

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus

CompletedNCT00361101

Genzyme, a Sanofi CompanyHIV Infections, X4 Tropic Virus

Start: 2005-10-31End: 2010-04-30Updated: 2014-02-11